{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:18:24Z","timestamp":1785161904020,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["AI067737"],"award-info":[{"award-number":["AI067737"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.vaccine.2012.03.039","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T09:30:00Z","timestamp":1333013400000},"page":"3405-3412","source":"Crossref","is-referenced-by-count":18,"title":["A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi"],"prefix":"10.1016","volume":"30","author":[{"given":"Ying-Jie","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Sayeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudette M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shousun","family":"Szu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Porter W.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.03.039_bib0005","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.03.039_bib0010","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4269\/ajtmh.2000.62.644","article-title":"The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam","volume":"62","author":"Lin","year":"2000","journal-title":"Am J Trop Med Hyg"},{"issue":"August (9180)","key":"10.1016\/j.vaccine.2012.03.039_bib0015","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","article-title":"Typhoid fever in children aged less than 5 years","volume":"354","author":"Sinha","year":"1999","journal-title":"Lancet"},{"issue":"September (9693)","key":"10.1016\/j.vaccine.2012.03.039_bib0020","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2012.03.039_bib0025","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/infdis\/150.3.436","article-title":"Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi","volume":"150","author":"Robbins","year":"1984","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.03.039_bib0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/IAI.74.1.19-27.2006","article-title":"Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis","volume":"74","author":"Raffatellu","year":"2006","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.03.039_bib0035","first-page":"830","article-title":"The Vi capsular polysaccharide prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi","volume":"79","author":"Wilson","year":"2010","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2012.03.039_bib0040","first-page":"625","article-title":"Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China","volume":"79","author":"Yang","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.03.039_bib0045","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-vi, and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2012.03.039_bib0050","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2012.03.039_bib0055","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2010.11.022","article-title":"Vi-CRM 197 as a new conjugate vaccine against Salmonella typhi","volume":"29","author":"Micoli","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.03.039_bib0060","first-page":"245","article-title":"Physico-chemical characterization and immunogenicity studies of peptide and polysaccharide conjugate vaccines based on a promising new carrier protein, the recombinant Klebsiella pneumoniae OmpA","volume":"103","author":"Haeuw","year":"2000","journal-title":"Dev Biol (Basel)"},{"issue":"May (20)","key":"10.1016\/j.vaccine.2012.03.039_bib0065","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1016\/j.vaccine.2006.03.002","article-title":"Evaluation of a novel Vi conjugate vaccine in a murine model of salmonellosis","volume":"24","author":"Hale","year":"2006","journal-title":"Vaccine"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.03.039_bib0070","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/IAI.57.12.3823-3827.1989","article-title":"Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi","volume":"57","author":"Szu","year":"1989","journal-title":"Infect Immun"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2012.03.039_bib0075","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1084\/jem.166.5.1510","article-title":"Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals","volume":"166","author":"Szu","year":"1987","journal-title":"J Exp Med"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.03.039_bib0080","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1128\/IAI.62.10.4440-4444.1994","article-title":"Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines","volume":"62","author":"Szu","year":"1994","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.03.039_bib0085","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/CVI.00387-10","article-title":"Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi","volume":"18","author":"Rondini","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.03.039_bib0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/CVI.00266-09","article-title":"Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates","volume":"17","author":"Cui","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.03.039_bib0095","first-page":"181","article-title":"Indian conjugate Vi typhoid vaccine: do we have enough evidence?","volume":"46","author":"Shah","year":"2009","journal-title":"Indian Pediatr"},{"issue":"October (Suppl. 2)","key":"10.1016\/j.vaccine.2012.03.039_bib0100","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17","author":"Levine","year":"1999","journal-title":"Vaccine"},{"issue":"October (8720)","key":"10.1016\/j.vaccine.2012.03.039_bib0105","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0140-6736(90)92266-K","article-title":"Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial","volume":"336","author":"Levine","year":"1990","journal-title":"Lancet"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.03.039_bib0110","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1586\/erv.09.113","article-title":"10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix","volume":"8","author":"Prymula","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2012.03.039_bib0115","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.vaccine.2006.11.032","article-title":"Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998\u20132006)","volume":"25","author":"Oosterhuis-Kafeja","year":"2007","journal-title":"Vaccine"},{"issue":"July (33)","key":"10.1016\/j.vaccine.2012.03.039_bib0120","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1016\/j.vaccine.2010.05.058","article-title":"Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines","volume":"28","author":"Chuck","year":"2010","journal-title":"Vaccine"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.03.039_bib0125","doi-asserted-by":"crossref","first-page":"e1000348","DOI":"10.1371\/journal.pmed.1000348","article-title":"Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project","volume":"7","author":"Johnson","year":"2010","journal-title":"PLoS Med"},{"issue":"April (9807)","key":"10.1016\/j.vaccine.2012.03.039_bib0130","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2012.03.039_bib0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10408410600822942","article-title":"Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies","volume":"32","author":"Tai","year":"2006","journal-title":"Crit Rev Microbiol"},{"issue":"August (1)","key":"10.1016\/j.vaccine.2012.03.039_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-8244(03)00146-9","article-title":"Novel vaccine strategies with protein antigens of Streptococcus pneumoniae","volume":"38","author":"Swiatlo","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"February (16)","key":"10.1016\/j.vaccine.2012.03.039_bib0145","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0264-410X(99)00511-3","article-title":"The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection","volume":"18","author":"Briles","year":"2000","journal-title":"Vaccine"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2012.03.039_bib0150","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.coi.2011.04.002","article-title":"Next generation pneumococcal vaccines","volume":"23","author":"Moffitt","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2012.03.039_bib0155","doi-asserted-by":"crossref","first-page":"e1000159","DOI":"10.1371\/journal.ppat.1000159","article-title":"Interleukin-17A mediates acquired immunity to pneumococcal colonization","volume":"4","author":"Lu","year":"2008","journal-title":"PLoS Pathog"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.03.039_bib0160","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1073\/pnas.0501254102","article-title":"CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization","volume":"102","author":"Malley","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.03.039_bib0165","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.1128\/IAI.73.11.7718-7726.2005","article-title":"Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model","volume":"73","author":"van Rossum","year":"2005","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.03.039_bib0170","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chom.2011.01.007","article-title":"T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization","volume":"9","author":"Moffitt","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.03.039_bib0175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00109-009-0579-4","article-title":"Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development","volume":"88","author":"Malley","year":"2010","journal-title":"J Mol Med"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.03.039_bib0180","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1128\/IAI.01554-08","article-title":"Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide","volume":"77","author":"Lu","year":"2009","journal-title":"Infect Immun"},{"issue":"November (47)","key":"10.1016\/j.vaccine.2012.03.039_bib0185","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1016\/j.vaccine.2010.09.031","article-title":"GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis","volume":"28","author":"Lu","year":"2010","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.03.039_bib0190","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/CVI.00036-10","article-title":"Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine","volume":"17","author":"Lu","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.03.039_bib0195","first-page":"351","article-title":"Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice","volume":"159","author":"Vintini","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.03.039_bib0200","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/IAI.73.2.981-989.2005","article-title":"PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model","volume":"73","author":"Green","year":"2005","journal-title":"Infect Immun"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2012.03.039_bib0205","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2249.2004.02628.x","article-title":"Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse","volume":"138","author":"Ling","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"August (1)","key":"10.1016\/j.vaccine.2012.03.039_bib0210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9258(18)56740-5","article-title":"The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application","volume":"180","author":"Hestrin","year":"1949","journal-title":"J Biol Chem"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.03.039_bib0215","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/IAI.69.8.4870-4873.2001","article-title":"Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci","volume":"69","author":"Malley","year":"2001","journal-title":"Infect Immun"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.03.039_bib0220","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1128\/IAI.74.4.2187-2195.2006","article-title":"Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide","volume":"74","author":"Malley","year":"2006","journal-title":"Infect Immun"},{"issue":"September (36)","key":"10.1016\/j.vaccine.2012.03.039_bib0225","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014United States, 1998\u20132003","volume":"54","author":"CDC","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.03.039_bib0230","first-page":"1899","article-title":"Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice","volume":"119","author":"Zhang","year":"2009","journal-title":"J Clin Invest"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2012.03.039_bib0235","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1046\/j.1432-1327.1999.00835.x","article-title":"The pneumococcal common antigen C-polysaccharide occurs in different forms. Mono-substituted or di-substituted with phosphocholine","volume":"265","author":"Karlsson","year":"1999","journal-title":"Eur J Biochem"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.03.039_bib0240","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.4049\/jimmunol.130.6.2871","article-title":"Resistance to Streptococcus pneumoniae is induced by a phosphocholine-protein conjugate","volume":"130","author":"Wallick","year":"1983","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.03.039_bib0245","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1128\/IAI.36.1.184-188.1982","article-title":"Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody","volume":"36","author":"Yother","year":"1982","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2012.03.039_bib0250","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1084\/jem.153.3.694","article-title":"Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae","volume":"153","author":"Briles","year":"1981","journal-title":"J Exp Med"},{"issue":"October (14)","key":"10.1016\/j.vaccine.2012.03.039_bib0255","first-page":"1390","article-title":"Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children","volume":"349","author":"Mai","year":"2003","journal-title":"N Engl J Med"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.03.039_bib0260","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"67","author":"Kossaczka","year":"1999","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.03.039_bib0265","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0021-9258(18)71120-4","article-title":"The determination of sugar in blood and spinal fluid with anthrone reagent","volume":"212","author":"Roe","year":"1955","journal-title":"J Biol Chem"},{"issue":"June (21\u201322)","key":"10.1016\/j.vaccine.2012.03.039_bib0270","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/S0264-410X(03)00177-4","article-title":"Immunogenicity of a new Salmonella typhi Vi polysaccharide vaccine\u2014vax-TyVi\u2014in Cuban school children and teenagers","volume":"21","author":"Azze","year":"2003","journal-title":"Vaccine"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2012.03.039_bib0275","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1073\/pnas.0910497107","article-title":"Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans","volume":"107","author":"Gondwe","year":"2010","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1200415X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1200415X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T10:12:09Z","timestamp":1713780729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1200415X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":55,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0264410X1200415X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.03.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}